MicroRNAs as pharmacological targets in endothelial cell function and dysfunction

Pharmacol Res. 2013 Sep:75:15-27. doi: 10.1016/j.phrs.2013.04.002. Epub 2013 Apr 18.

Abstract

Endothelial cell dysfunction is a term which implies the dysregulation of normal endothelial cell functions, including impairment of the barrier functions, control of vascular tone, disturbance of proliferative, migratory and morphogenic capacities of endothelial cells, as well as control of leukocyte trafficking. MicroRNAs are short non-coding RNAs that have emerged as critical regulators of gene expression acting predominantly at the post-transcriptional level. This review summarizes the latest insights in the identification of endothelial-specific microRNAs and their targets, as well as their roles in controlling endothelial cell functions in both autocrine and paracrine manner. In addition, we discuss the therapeutic potential for the treatment of endothelial cell dysfunction and associated vascular pathophysiological conditions.

Keywords: Endothelial cell dysfunction; Endothelial cells; MicroRNA therapeutics; MicroRNAs; Vascular disease.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cardiovascular Diseases / genetics
  • Cardiovascular Diseases / immunology
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / therapy*
  • Cell Differentiation / drug effects
  • Endothelial Cells* / immunology
  • Endothelial Cells* / pathology
  • Endothelium, Vascular / immunology
  • Endothelium, Vascular / metabolism
  • Endothelium, Vascular / pathology
  • Endothelium, Vascular / physiopathology*
  • Gene Expression Regulation
  • Gene Targeting / methods*
  • Genetic Therapy / methods*
  • Hemodynamics / genetics
  • Hemodynamics / physiology
  • Humans
  • MicroRNAs / antagonists & inhibitors
  • MicroRNAs / biosynthesis
  • MicroRNAs / genetics*

Substances

  • MicroRNAs